Hostname: page-component-7479d7b7d-8zxtt Total loading time: 0 Render date: 2024-07-10T18:49:44.164Z Has data issue: false hasContentIssue false

QT Prolongation: Psychotropic medication versus illicit drugs

Published online by Cambridge University Press:  01 September 2022

A. Florian*
Affiliation:
“Prof. Dr. Al. Obregia” Psychiatry Clinical Hospital, Child And Adolescent Psychiatry, Bucharest, Romania
C. Florian
Affiliation:
“Prof. Dr. Al. Obregia” Psychiatry Clinical Hospital, Child And Adolescent Psychiatry, Bucharest, Romania
A. Ignat
Affiliation:
“Prof. Dr. Al. Obregia” Psychiatry Clinical Hospital, Child And Adolescent Psychiatry, Bucharest, Romania
C. Voinea
Affiliation:
“Prof. Dr. Al. Obregia” Psychiatry Clinical Hospital, Child And Adolescent Psychiatry, Bucharest, Romania
L. Popescu
Affiliation:
“Prof. Dr. Al. Obregia” Psychiatry Clinical Hospital, Child And Adolescent Psychiatry, Bucharest, Romania
G. Ganea
Affiliation:
Emergency Clinical Hospital for Children “M.S.Curie”, Pediatric Cardiology, Bucharest, Romania
C. Gherghe
Affiliation:
Central Military Emergency Hospital “Dr. Carol Davila”, Psychiatry, Bucharest, Romania
L. Mateescu
Affiliation:
“Prof. Dr. Al. Obregia” Psychiatry Clinical Hospital, Child And Adolescent Psychiatry, Bucharest, Romania Carol Davila University of Medicine and Pharmacy, Child And Adolescent Psychiatry, Bucharest, Romania
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Countless substances used for their psychotropic effects may induce adverse cardiac effects, such as QT prolongation. This category of substances holds illicit drugs as well as medications, with their effects influenced by dosage, concomitant use and patient specific factors. The appraisal of cardiac consequences is essential as delayed repolarization may lead to the rare but potentially deadly polymorphic ventricular tachycardia.

Objectives

The goal of this presentation is to underscore the cardiac risks associated with both medication use and substance abuse in order to ensure the suitable psychopharmacological treatment, especially in particular situations of drug using patients.

Methods

The subject of the presentation is a 17-year-old female adolescent hospitalized in our clinic, with multiple substance abuse, as seen in qualitative multidrug test (cannabis, amphetamines, ecstasy, barbiturates, benzodiazepines), previously under complex treatment prescribed by an adult psychiatrist (3 atypical antipsychotics, 1 selective serotonin reuptake inhibitor, 1 anticonvulsant, 1 benzodiazepine). Specialty literature has been reviewed concerning the cardiac effects of both the abuse substances and the psychiatric medications.

Results

Multiple drugs involved may cause a myocardial repolarization delay, the patient having a QTc of 508 msec at the admission. Consequent to parenteral fluids and treatment managing, ECG revealed a decrease to 379 msec 7 days later in the stay. This finding could not be viewed solely as caused by drug use, psychiatric medication or individual factors, but rather as their aggregation.

Conclusions

Psychotropic substances use may lead to QT prolongation, which calls for close cardiac supervision whenever patient’s behaviour warrants or when pharmacologic intervention is required.

Disclosure

No significant relationships.

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.